At the BSRA meeting, held in Manchester, Loren presented the research she carried out as a DPhil student, and now a postdoc, at NDORMS. Her presentation, titled “The mTOR-ment of ageing”, explored how the mTOR inhibitor rapamycin, one of the most potent life-extending drugs known to date, enhances resilience against DNA damage in the ageing immune system.
As the winner of the first place Korenchevsky Prize, the BSRA will fund Loren to attend and present her work at the American Aging Association’s Annual conference in 2026 in Utah.
On receiving the award, Loren said, “I’m really pleased for my work to be recognised by this generous award, and I’m excited to be going to the US next year to connect with fellow gerontologists who are doing some fantastic research”.
Loren joined the Alsaleh Group within NDORMS in 2022 during her DPhil at the Department of Biochemistry. Her work has investigated human immune system ageing throughout both her BSc Immunology and Infection at University College London, and during her DPhil at NDORMS and Biochemistry. She is now continuing her research as a postdoc, focusing on interventions that rejuvenate immune responses in old age by their ability to modulate mTOR activity, DNA damage, and cell senescence.